Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Kallay L, Gawali VS, Toukam DK, Bhattacharya D, Jenkins A, Sengupta S, Pomeranz Krummel DA. Screening Ion Channels in Cancer Cells. J Vis Exp. 2023 Jun 16;(196). doi: 10.3791/65427. PubMed PMID: 37395566.
Darabi S, Xiu J, Samec T, Kesari S, Carrillo J, Aulakh S, Walsh KM, Sengupta S, Sumrall A, Spetzler D, Glantz M, Demeure MJ. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. Med Oncol. 2023 Jun 8;40(7):197. doi: 10.1007/s12032-023-02071-0. PubMed PMID: 37291277; PubMed Central PMCID: PMC10250263.
Rao R, Patel A, Hanchate K, Robinson E, Edwards A, Shah S, Higgins D, Haworth KJ, Lucke-Wold B, Pomeranz Krummel D, Sengupta S. Advances in Focused Ultrasound for the Treatment of Brain Tumors. Tomography. 2023 May 29;9(3):1094-1109. doi: 10.3390/tomography9030090. Review. PubMed PMID: 37368542; PubMed Central PMCID: PMC10301958.
Hey G, Rao R, Carter A, Reddy A, Valle D, Patel A, Patel D, Lucke-Wold B, Pomeranz Krummel D, Sengupta S. Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas. J Pers Med. 2023 May 19;13(5). doi: 10.3390/jpm13050853. Review. PubMed PMID: 37241023; PubMed Central PMCID: PMC10224160.
Ranjan T, Sengupta S, Glantz MJ, Green RM, Yu A, Aregawi D, Chaudhary R, Chen R, Zuccarello M, Lu-Emerson C, Moulding HD, Belman N, Glass J, Mammoser A, Anderson M, Valluri J, Marko N, Schroeder J, Jubelirer S, Chow F, Claudio PP, Alberico AM, Lirette ST, Denning KL, Howard CM. Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial. Cell Rep Med. 2023 May 16;4(5):101025. doi: 10.1016/j.xcrm.2023.101025. Epub 2023 May 2. PubMed PMID: 37137304; PubMed Central PMCID: PMC10213810.
Sengupta S. Integrative neuro-oncology for brain tumor patients. J Neurooncol. 2023 May;163(1):289-290. doi: 10.1007/s11060-023-04309-3. Epub 2023 Apr 25. PubMed PMID: 37097501.
Lechpammer M, Mahammedi A, Pomeranz Krummel DA, Sengupta S. Lessons learned from evolving frameworks in adult glioblastoma. Handb Clin Neurol. 2023;192:131-140. doi: 10.1016/B978-0-323-85538-9.00011-0. Review. PubMed PMID: 36796938.
Rao R, Koehler A, Beckett K, Sengupta S. COVID-19 Vaccine Mandates for Healthcare Professionals in the United States. Vaccines (Basel). 2022 Aug 30;10(9). doi: 10.3390/vaccines10091425. PubMed PMID: 36146503; PubMed Central PMCID: PMC9504674.
Koehler A, Rao R, Rothman Y, Gozal YM, Struve T, Alschuler L, Sengupta S. A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient. Integr Cancer Ther. 2022 Jan-Dec;21:15347354211068417. doi: 10.1177/15347354211068417. PubMed PMID: 34984951; PubMed Central PMCID: PMC8753228.
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses. iScience. 2021 Oct 22;24(10):103115. doi: 10.1016/j.isci.2021.103115. Epub 2021 Sep 10. PubMed PMID: 34522848; PubMed Central PMCID: PMC8428985.
Bhattacharya D, Gawali VS, Kallay L, Toukam DK, Koehler A, Stambrook P, Krummel DP, Sengupta S. Therapeutically leveraging GABA(A) receptors in cancer. Exp Biol Med (Maywood). 2021 Oct;246(19):2128-2135. doi: 10.1177/15353702211032549. Review. PubMed PMID: 34649481; PubMed Central PMCID: PMC8524771.
Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal. bioRxiv. 2021 Jun 16;. doi: 10.1101/2021.06.07.447287. PubMed PMID: 34127975; PubMed Central PMCID: PMC8202427.
Guo Y, Lee H, Fang Z, Velalopoulou A, Kim J, Thomas MB, Liu J, Abramowitz RG, Kim Y, Coskun AF, Krummel DP, Sengupta S, MacDonald TJ, Arvanitis C. Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles. Sci Adv. 2021 Apr;7(18). doi: 10.1126/sciadv.abf7390. Print 2021 Apr. PubMed PMID: 33931452; PubMed Central PMCID: PMC8087400.
Sengupta S, Pater LE, Krummel DP, Aronow BJ, Hirota Y, Phoenix TN, Sasaki AT. Integration of Molecular Analysis, Cutting-edge Mouse Genetic Models and Proton Therapy to Improve Outcomes for Glioma Patients. 2021 Apr 30;. doi: 10.36255/exonpublications.gliomas.2021.chapter5. Review. PubMed PMID: 34038048.
Pomeranz Krummel DA, Nasti TH, Kaluzova M, Kallay L, Bhattacharya D, Melms JC, Izar B, Xu M, Burnham A, Ahmed T, Li G, Lawson D, Kowalski J, Cao Y, Switchenko JM, Ionascu D, Cook JM, Medvedovic M, Jenkins A, Khan MK, Sengupta S. Melanoma Cell Intrinsic GABA(A) Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):1040-1053. doi: 10.1016/j.ijrobp.2020.10.025. Epub 2020 Oct 24. PubMed PMID: 33289666; PubMed Central PMCID: PMC8329598.
Koehler A, Karve A, Desai P, Arbiser J, Plas DR, Qi X, Read RD, Sasaki AT, Gawali VS, Toukam DK, Bhattacharya D, Kallay L, Pomeranz Krummel DA, Sengupta S. Reuse of Molecules for Glioblastoma Therapy. Pharmaceuticals (Basel). 2021 Jan 28;14(2). doi: 10.3390/ph14020099. Review. PubMed PMID: 33525329; PubMed Central PMCID: PMC7912673.
Worrell SL, Kirschner ML, Shatz RS, Sengupta S, Erickson MG. Interdisciplinary Approaches to Survivorship with a Focus on the Low-grade and Benign Brain Tumor Populations. Curr Oncol Rep. 2021 Jan 20;23(2):19. doi: 10.1007/s11912-020-01004-8. Review. PubMed PMID: 33471214; PubMed Central PMCID: PMC7817573.
Bachir S, Shah S, Shapiro S, Koehler A, Mahammedi A, Samy RN, Zuccarello M, Schorry E, Sengupta S. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int J Mol Sci. 2021 Jan 12;22(2). doi: 10.3390/ijms22020690. Review. PubMed PMID: 33445724; PubMed Central PMCID: PMC7828193.
Gallia GL, Holdhoff M, Brem H, Joshi AD, Hann CL, Bai RY, Staedtke V, Blakeley JO, Sengupta S, Jarrell TC, Wollett J, Szajna K, Helie N, Mattox AK, Ye X, Rudek MA, Riggins GJ. Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial. Neurooncol Adv. 2021 Jan-Dec;3(1):vdaa154. doi: 10.1093/noajnl/vdaa154. eCollection 2021 Jan-Dec. PubMed PMID: 33506200; PubMed Central PMCID: PMC7817892.
Koehler A, Rothman Y, Gibson J, Krischner M, Turner B, Charif M, Mahammedi A, Forbes J, Sengupta S. Bevacizumab and Optune Combination in Treating Newly Diagnosed GBM: Case Study. Clinics in oncology (Belmont, Calif.). 2020 November; 5:1-3.
Mahammedi A, Saba L, Vagal A, Leali M, Rossi A, Gaskill M, Sengupta S, Zhang B, Carriero A, Bachir S, Crivelli P, Paschè A, Premi E, Padovani A, Gasparotti R. Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study. Radiology. 2020 Nov;297(2):E270-E273. doi: 10.1148/radiol.2020201933. Epub 2020 May 21. PubMed PMID: 32437313; PubMed Central PMCID: PMC7587295.
Bhattacharya D, Pomeroy SL, Pomeranz Krummel DA, Sengupta S. Epigenetics and survivorship in pediatric brain tumor patients. J Neurooncol. 2020 Oct;150(1):77-83. doi: 10.1007/s11060-020-03535-3. Epub 2020 May 25. Review. PubMed PMID: 32451770.
Pomeranz Krummel DA, Nasti TH, Izar B, Press RH, Xu M, Lowder L, Kallay L, Rupji M, Rosen H, Su J, Curran W, Olson J, Weinberg B, Schniederjan M, Neill S, Lawson D, Kowalski J, Khan MK, Sengupta S. Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):157-163. doi: 10.1016/j.ijrobp.2020.01.043. Epub 2020 Feb 11. PubMed PMID: 32057994; PubMed Central PMCID: PMC7839060.
Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan TM, Behera M, Sengupta S, Voloschin AD, Olson JJ, Hasan S, Blumenthal DT, Curran WJ, Eaton BR, Shu HG, Zhong J. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification. Cancer. 2020 Jul 15;126(14):3255-3264. doi: 10.1002/cncr.32797. Epub 2020 Apr 28. PubMed PMID: 32342992.
Karschnia P, Sengupta S, Dietrich J. MRI findings in trigeminal neuropathy: bilateral Meckel's cave lesions. Acta Neurol Belg. 2020 Feb;120(1):171-173. doi: 10.1007/s13760-019-01091-w. Epub 2019 Feb 2. PubMed PMID: 30712245.
Sadigh G, Gallagher K, Obenchain J, Benson A 3rd, Mitchell E, Sengupta S, Carlos RC. Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients. J Am Coll Radiol. 2019 Oct;16(10):1420-1424. doi: 10.1016/j.jacr.2019.07.014. PubMed PMID: 31585660; PubMed Central PMCID: PMC6779332.
Cicka D, Ford CL, Templin E, Pitts Z, Gurbani S, Eaton B, Lowder L, Olson J, Weinberg BD, Shim H, Sengupta S. Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy. Oxf Med Case Reports. 2019 Sep;2019(9):omz085. doi: 10.1093/omcr/omz085. eCollection 2019 Sep. PubMed PMID: 31772751; PubMed Central PMCID: PMC6765376.
Lowder L, Hauenstein J, Woods A, Chen HR, Rupji M, Kowalski J, Olson JJ, Saxe D, Schniederjan M, Neill S, Weinberg B, Sengupta S. Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis. J Neurooncol. 2019 Jul;143(3):381-392. doi: 10.1007/s11060-019-03184-1. Epub 2019 May 9. PubMed PMID: 31073965; PubMed Central PMCID: PMC6591191.
Kallay L, Keskin H, Ross A, Rupji M, Moody OA, Wang X, Li G, Ahmed T, Rashid F, Stephen MR, Cottrill KA, Nuckols TA, Xu M, Martinson DE, Tranghese F, Pei Y, Cook JM, Kowalski J, Taylor MD, Jenkins A, Pomeranz Krummel DA, Sengupta S. Modulating native GABA(A) receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. J Neurooncol. 2019 May;142(3):411-422. doi: 10.1007/s11060-019-03115-0. Epub 2019 Feb 6. PubMed PMID: 30725256; PubMed Central PMCID: PMC6478651.
Sengupta S, Pomeranz Krummel D, MacDonald T. High-Grade Tumors of the Brainstem (Except DIPG).. In: Jallo EG, Noureldine M, Shimony N, editors. Brainstem Tumors: Diagnosis and Management. US: Springer; 2019.
Doyle SP, Gurbani SS, Ross AS, Rosen H, Barrett CD, Olson JJ, Shim H, Shu HK, Sengupta S. The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma. Oxf Med Case Reports. 2018 Dec;2018(12):omy095. doi: 10.1093/omcr/omy095. eCollection 2018 Dec. PubMed PMID: 30410775; PubMed Central PMCID: PMC6217712.
Clark AR, Calligaris D, Regan MS, Pomeranz Krummel D, Agar JN, Kallay L, MacDonald T, Schniederjan M, Santagata S, Pomeroy SL, Agar NYR, Sengupta S. Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. J Neurooncol. 2018 Nov;140(2):269-279. doi: 10.1007/s11060-018-2978-2. Epub 2018 Aug 20. PubMed PMID: 30128689; PubMed Central PMCID: PMC6244779.
Melms JC, Ho KW, Thummalapalli R, Tyler J, Brinker TJ, Singh V, Sengupta S, Mier J, Izar B. Implementation of cell-free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report. Mol Clin Oncol. 2018 Jul;9(1):58-61. doi: 10.3892/mco.2018.1621. Epub 2018 May 9. PubMed PMID: 29977540; PubMed Central PMCID: PMC6030997.
Sengupta S. Intravascular Lymphoma – Uncommon Causes of Stroke. In: Caplan LR, Billier J, editors. Stroke In press: CUP; 2018.
Lee E, Sengupta S, Wen P. Neurological Complications of Cancer. In: Scientific American Medicine Canadian: Decker; 2018.
Rosen H, Patel R, Sengupta S, Zarrabi A. The Benefit of Palliative Care on Brain Cancer Patient’s Quality of Life. EC Neurology. 2018; 10(7):532-535.
Archer TC, Sengupta S, Pomeroy SL. Brain Cancer Genomics and Epigenomics. In: Handbook of Clinical Neurology Amsterdam, Netherlands: Elsevier; 2018.
Abedalthagafi M, Sengupta S, Huang R, Ligon K. DEDIFFERENTIATED” GLIOBLASTOMA: A CLINICOPATHOLOGICAL AND MOLECULAR STUDY. Society of Neuro-Oncology Meeting; 2017 November 15; Neuro-Oncology; c2017.
Gurbani S, Sengupta S, Olson J, Shu H, Shim H. ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101). Society of Neuro-Oncology Meeting; 2017 November 15; Neuro-Oncology; c2017.
Calligaris D, Clark A, Kallay L, Pomeranz Krummel D, Agar J, Schniederjan M, Pomeroy S, Agar N, Sengupta S. DISTINGUISHING PINEOBLASTOMA FROM MEDULLOBLASTOMAS USING TISSUE MASS SPECTROMETRY IMAGING. Society of Neuro-Oncology Meeting; 2017 November 15; Neuro-Oncology; c2017.
Kallay L, Ross A, Moody O, Cook J, MacDonald T, Jenkins A, Pomeranz Krummel D, Sengupta S. UNDERSTANDING THE MECHANISM OF BENZODIAZEPINE MEDIATED CELL DEATH IN GABRA5 OVEREXPRESSING GROUP 3 MEDULLOBLASTOMAS. Society of Neuro-Oncology Meeting; 2017 November 15; Neuro-Oncology; c2017.
Sengupta S, Pomeranz Krummel D, Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine. F1000Res. 2017;6:490. doi: 10.12688/f1000research.10859.1. eCollection 2017. Review. PubMed PMID: 28713553; PubMed Central PMCID: PMC5490254.
Sengupta S, Voloschin A. Redefining Management of Adult Low-Grade Gliomas. J Oncol Pract. 2016 Dec;12(12):1244-1245. doi: 10.1200/JOP.2016.019174. PubMed PMID: 27943688.
Kallay L, Pomeranz Krummel D, Sydlik S, Sengupta S. TARGETING MEDULLOBLASTOMA WITH BENZODIAZAPINES DELIVERED USING TUNABLE BIODEGRADABLE HYDROGELS. Society of Neuro-Oncology Meeting; 2016 November 15; c2016.
Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F, Changelian A, Sieghart W, Ernst M, Krummel DA, Cook JM, Pomeroy SL, Cima M, Agar NY, Langer R, Sengupta S. First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. J Biomed Nanotechnol. 2016 Jun;12(6):1297-302. doi: 10.1166/jbn.2016.2262. PubMed PMID: 27319222; PubMed Central PMCID: PMC5293728.
Sengupta S, Gerstner E. Brain Tumors and Pregnancy. In: Klein A, O'Neal M, Scifres C, Waters J, Waters J, editors. Neurological Illness in Pregnancy: Principles & Practice Chichester, West Sussex, UK: Wiley Blackwell; 2016. Chapter 13.
Mahadevan A, Sampson C, LaRosa S, Floyd SR, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy. Radiat Oncol. 2015 Nov 26;10:245. doi: 10.1186/s13014-015-0555-9. PubMed PMID: 26611656; PubMed Central PMCID: PMC4662000.
Ippen FM, Mahadevan A, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM. Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection. J Oncol. 2015;2015:636918. doi: 10.1155/2015/636918. Epub 2015 Nov 19. PubMed PMID: 26681942; PubMed Central PMCID: PMC4668321.
Sengupta S, Rojas R, Mahadevan A, Kasper E, Jeyapalan S. CPT-11/bevacizumab for the treatment of refractory brain metastases in patients with HER2-neu-positive breast cancer. Oxf Med Case Reports. 2015 Apr;2015(4):254-7. doi: 10.1093/omcr/omv010. eCollection 2015 Apr. PubMed PMID: 26634139; PubMed Central PMCID: PMC4664841.
Sengupta S, Benkers T, Blitstein M, Palmer E, Plotkin SR, Abramson JS. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):e111-3. doi: 10.1016/j.clml.2014.01.005. Epub 2014 Feb 2. PubMed PMID: 24581553.
What would you like to do?